Navigation Links
Bobbi Drais Promoted to Vice President, Regulatory Affairs for HEALTHPOINT, Ltd.

FORT WORTH, Texas, May 7 /PRNewswire/ -- HEALTHPOINT, Ltd., a DFB Pharmaceuticals, Inc. company, has announced the promotion of Bobbi Drais to Vice President of Regulatory Affairs. Ms. Drais, with 15 years of regulatory experience, was most recently Senior Director of Regulatory Affairs for the company.

Since joining Healthpoint in 2003, Ms. Drais has achieved landmark regulatory success for DFB and Healthpoint. Ms. Drais initially established the regulatory department for Healthpoint. She and her team secured new drug approval (NDA) and marketing authorization approval (MAA) for ATRALIN(TM) (tretinoin) Gel in the US and Europe, respectively, the first Healthpoint proprietary product to achieve such approval. Ms. Drais was also instrumental in gaining regulatory approval of Collagenase SANTYL(R) Ointment in Canada.

"With Bobbi at the helm of all regulatory functions, I have great confidence that Healthpoint can seamlessly continue along its trajectory of success," said Travis E. Baugh, President of Healthpoint. "We're fortunate to have such a seasoned professional in this role as we navigate the regulatory waters. We count on her tremendously."

Prior to joining the DFB family of companies, Ms. Drais was Regulatory Affairs Manager for Galderma Laboratories, LP, Carrington Laboratories, Inc. and Smith & Nephew, Inc.

Ms. Drais graduated from Messiah College in Grantham, Pa., with a Bachelor of Science degree in biology. She also earned a Master of Science degree in microbiology from the University of South Florida in Tampa, Fla. Ms. Drais maintains memberships in the Regulatory Affairs Professional Society and the Drug Information Association, and she holds a Regulatory Affairs Certification (RAC).

Since 1992, HEALTHPOINT has been dedicated to innovative technologies for the prevention and treatment of acute, chronic and burn-related wounds. The company is presently focused on the research and development of novel biologics and pharmaceuticals intended to improve clinical and quality of life outcomes. Currently marketed products include: Collagenase SANTYL(R) Ointment, OASIS(R) Wound Matrix, HYDROFERA BLUE(R) Bacteriostatic Wound Dressings, and SURGICEPT(R) Waterless Surgical Hand Antiseptic. HEALTHPOINT is also committed to advancing the care and treatment of wounds through support of industry leading continuing education from THE WOUND INSTITUTE(R). To learn more about this comprehensive and award winning educational resource, please visit HEALTHPOINT is a DFB Pharmaceuticals, Inc. affiliate company, and is based in Fort Worth, Texas. For more information, visit the HEALTHPOINT website at

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
2. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
3. CWs 7th Heaven Actress Mackenzie Rosman to Visit Birmingham Area High School to Honor Cystic Fibrosis Foundation Fundraising
4. Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis
5. Khanna Institute Supports Oaks Christian School's Annual Fundraiser
6. Maryland Mystery Author Organizes Fundraising Ride for Rare Neurological Disorder
7. West Coast Bank Sponsors Reach the Beach Cycling Fundraiser to Support the American Lung Association
8. Country Star Phil Vassar to Perform at Transplantation Fundraiser
9. American Airlines Applauded for Its Fundraising to Support Susan G. Komen for the Cure(R), Promise Grant to The University of Texas M. D. Anderson Cancer Center
10. Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign
11. Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: